LYMPHANGIOMYOMATOSIS RECURRENCE IN THE ALLOGRAFT AFTER SINGLE-LUNG TRANSPLANTATION

The evolution of lung transplantation has offered an additional treatm ent option for patients with a variety of end-stage lung diseases, inc luding some with systemic disorders. Lymphangiomyomatosis (LAM) is a m ultisystem disease of premenopausal women. The lung is the most freque ntly involved vital organ, and respiratory failure is the most common case of death. A small number of patients with LAM have undergone lung transplantation. This report describes a case of recurrent LAM in the allograft after single lung transplantation and discusses the implica tions of this finding.